These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3527821)

  • 21. New hepatitis B vaccines.
    Zuckerman AJ
    Br Med J (Clin Res Ed); 1985 Feb; 290(6467):492-6. PubMed ID: 3918647
    [No Abstract]   [Full Text] [Related]  

  • 22. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B virus proteins eliciting protective immunity.
    Neurath AR; Jameson BA; Huima T
    Microbiol Sci; 1987 Feb; 4(2):45-51. PubMed ID: 3153169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B vaccine: extending immunogenicity.
    Horton RC
    Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination against hepatitis B--the current situation.
    Jilg W; Deinhardt F
    Infection; 1986; 14(3):100-1. PubMed ID: 2942487
    [No Abstract]   [Full Text] [Related]  

  • 27. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine.
    André FE
    Am J Med; 1989 Sep; 87(3A):14S-20S. PubMed ID: 2528292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects for second and third generation hepatitis B vaccines.
    Purcell RH; Gerin JL
    Hepatology; 1985; 5(1):159-63. PubMed ID: 3967858
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B vaccine.
    Capiau C
    Dev Biol Stand; 1998; 96():127-9. PubMed ID: 9890526
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

  • 32. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation on expression of the recombinant S gene of human hepatitis B virus in vitro and in vivo.
    Yang RY; Zeng QP; Fu LC; Chen ZT
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):259-64. PubMed ID: 14599980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus. Application of recombinant DNA technics to the development of hepatitis B vaccines and its diagnosis].
    Hamada F
    Rinsho Byori; 1988 May; 36(5):548-52. PubMed ID: 2971829
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant yeast-derived hepatitis B vaccine: the prototype for biotechnologically derived old vaccines.
    Ellis RW
    Bioprocess Technol; 1991; 13():355-69. PubMed ID: 1368626
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis prophylaxis.
    Aach RD
    Johns Hopkins Med J; 1982 Dec; 151(6):318-25. PubMed ID: 6184517
    [No Abstract]   [Full Text] [Related]  

  • 37. Newer directions in vaccine development and utilization.
    Hilleman MR
    J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities of eradicating the persistent HBsAg carrier state].
    Farber NA; Ambrozaĭtis AK; Kelli EI; Vygodskiĭ VS; Savitskiĭ GI
    Ter Arkh; 1984; 56(11):99-103. PubMed ID: 6523400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.